Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.5979
+0.0369 (6.58%)
At close: Oct 15, 2026, 4:00 PM EDT
0.5680
-0.0299 (-5.00%)
After-hours: Oct 15, 2026, 7:58 PM EDT

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $1.16M in the quarter ending June 30, 2026, a decrease of -15.10%. This brings the company's revenue in the last twelve months to $4.50M, down -39.29% year-over-year. In the year 2025, Ensysce Biosciences had annual revenue of $5.07M, down -2.75%. That makes Ensysce Biosciences the 40,260th largest company in the world by revenue and 5,368th in the United States.

Revenue (ttm)
$4.50M
Revenue Growth
-39.29%
P/S Ratio
2.51
Revenue / Employee
$450,075
Employees
10
Market Cap
11.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.07M-143.38K-2.75%
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M--
Dec 31, 2019---
Dec 31, 2018---